• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活检中的局部环境更能预测直肠癌新辅助放化疗的病理反应。

Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer.

机构信息

Department of Pathology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China.

Department of Orthopedics, Guangzhou Huaxin Orthopedic Hospital, Guangzhou, China.

出版信息

Biosci Rep. 2019 Mar 26;39(3). doi: 10.1042/BSR20190003. Print 2019 Mar 29.

DOI:10.1042/BSR20190003
PMID:30867256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6434387/
Abstract

Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is the standard treatment for locally advanced rectal cancer. Here, we analyzed the impact of local and systemic environments on the tumor response to preoperative chemoradiotherapy in rectal cancer. We recruited 141 patients with rectal cancer treated with nCRT. We evaluated the local tumor environment, including tumor-infiltrating lymphocytes (TILs), intratumor budding (ITB), and the systemic inflammatory environment, including the neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) level. Our finding revealed that tumor regression was significantly associated with the density of CD8+ TILs in the intraepithelial, the presence of ITB, the combination of NLR and CRP (NLR-CRP) value, and the combination of CD8+ intraepithelial TIL (iTIL) density and ITB presence. Moreover, multivariate analysis showed that only the combination of CD8+ iTILs and ITB was an independent predictive factor for the pathological response to nCRT in rectal cancer. Our finding demonstrate that the local tumor environment was a better predictor of the tumor response than the systemic environment and thus provided new insight into screening for patients who are more likely to benefit from cancer treatment.

摘要

新辅助放化疗(nCRT)后手术是局部进展期直肠癌的标准治疗方法。在这里,我们分析了局部和全身环境对直肠癌术前放化疗肿瘤反应的影响。我们招募了 141 例接受 nCRT 治疗的直肠癌患者。我们评估了局部肿瘤环境,包括肿瘤浸润淋巴细胞(TILs)、肿瘤内芽(ITB)以及全身炎症环境,包括中性粒细胞与淋巴细胞比值(NLR)和 C 反应蛋白(CRP)水平。我们的研究结果表明,肿瘤消退与上皮内 CD8+TILs 的密度、ITB 的存在、NLR 和 CRP(NLR-CRP)值的组合以及 CD8+上皮内 TIL(iTIL)密度和 ITB 存在的组合显著相关。此外,多变量分析表明,只有 CD8+iTILs 和 ITB 的组合是直肠癌 nCRT 病理反应的独立预测因素。我们的研究结果表明,局部肿瘤环境是预测肿瘤反应的更好指标,而不是全身环境,从而为筛选更有可能从癌症治疗中获益的患者提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/6434387/f0ff27dbebe5/bsr-39-bsr20190003-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/6434387/8fa801ae9303/bsr-39-bsr20190003-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/6434387/f0ff27dbebe5/bsr-39-bsr20190003-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/6434387/8fa801ae9303/bsr-39-bsr20190003-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e46/6434387/f0ff27dbebe5/bsr-39-bsr20190003-g2.jpg

相似文献

1
Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer.活检中的局部环境更能预测直肠癌新辅助放化疗的病理反应。
Biosci Rep. 2019 Mar 26;39(3). doi: 10.1042/BSR20190003. Print 2019 Mar 29.
2
Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.新辅助治疗前后直肠癌肿瘤浸润淋巴细胞的意义
Cancer Sci. 2018 Apr;109(4):966-979. doi: 10.1111/cas.13542. Epub 2018 Mar 25.
3
Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.直肠癌新辅助放化疗前后肿瘤浸润淋巴细胞、叉头框蛋白P3、程序性死亡配体1及细胞毒性T淋巴细胞相关抗原4的表达情况
Transl Res. 2015 Dec;166(6):721-732.e1. doi: 10.1016/j.trsl.2015.06.019. Epub 2015 Jul 6.
4
Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.直肠癌放化疗开始后 7 天获得的活检标本中的肿瘤浸润淋巴细胞是预测放化疗反应的标志物。
Oncology. 2020;98(12):869-875. doi: 10.1159/000508922. Epub 2020 Aug 14.
5
Intratumoral Budding and CD8-Positive T-cell Density in Pretreatment Biopsies as a Predictor of Response to Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer.术前活检中的肿瘤内芽生和 CD8 阳性 T 细胞密度可预测晚期直肠癌新辅助放化疗的反应。
Clin Colorectal Cancer. 2023 Dec;22(4):411-420.e1. doi: 10.1016/j.clcc.2023.07.004. Epub 2023 Jul 22.
6
CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.直肠癌放化疗前后CD8 +和FOXP3 +肿瘤浸润性T细胞
Ann Surg Oncol. 2014 Jun;21 Suppl 3:S414-21. doi: 10.1245/s10434-014-3584-y. Epub 2014 Feb 25.
7
C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.C 反应蛋白可预测行放化疗后手术治疗的直肠癌患者的复发情况。
Anticancer Res. 2013 Nov;33(11):5065-74.
8
Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma.直肠腺癌新辅助治疗疗效的预测指标:预处理活检中肿瘤内芽生和 CD8 阳性 T 细胞密度的自动化分析
Mod Pathol. 2021 Jan;34(1):171-183. doi: 10.1038/s41379-020-0619-8. Epub 2020 Jul 13.
9
Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?新辅助放化疗后直肠癌肿瘤浸润 CD8+ 淋巴细胞的预后价值:吲哚胺 2,3-双加氧酶 (IDO1) 是朋友还是敌人?
Cancer Immunol Immunother. 2019 Apr;68(4):563-575. doi: 10.1007/s00262-019-02306-y. Epub 2019 Jan 22.
10
Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.直肠癌新辅助放化疗前肿瘤浸润调节性T细胞密度不能预测治疗反应。
Oncotarget. 2017 Mar 21;8(12):19803-19813. doi: 10.18632/oncotarget.15048.

引用本文的文献

1
Association of clinical biomarkers and response to neoadjuvant therapy in breast cancer.乳腺癌中临床生物标志物与新辅助治疗反应的关系。
Ir J Med Sci. 2024 Apr;193(2):605-613. doi: 10.1007/s11845-023-03489-1. Epub 2023 Sep 7.
2
IMMUNOREACT 0: Biopsy-based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer-A systematic review and meta-analysis.免疫反应 0:基于活检的免疫生物标志物预测直肠癌新辅助治疗的反应-系统评价和荟萃分析。
Cancer Med. 2023 Sep;12(17):17878-17890. doi: 10.1002/cam4.6423. Epub 2023 Aug 3.
3
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8 T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma.

本文引用的文献

1
Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy.系统性炎症标志物对接受一线化疗的转移性睾丸生殖细胞肿瘤患者具有独立的预后价值。
Br J Cancer. 2018 Mar 20;118(6):825-830. doi: 10.1038/bjc.2017.467. Epub 2018 Feb 27.
2
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
Tumor budding is a prognostic factor linked to epithelial mesenchymal transition in pancreatic ductal adenocarcinoma. Study report and literature review.
术前活检中的 I 型干扰素足迹是一个独立的生物标志物,与 CD8 T 细胞定量相结合可以提高对直肠腺癌新辅助治疗反应的预测。
Oncoimmunology. 2023 May 10;12(1):2209473. doi: 10.1080/2162402X.2023.2209473. eCollection 2023.
4
Clinicopathological Significances and Prognostic Role of Intratumoral Budding in Colorectal Cancers.结直肠癌瘤内芽生的临床病理意义及预后作用
J Clin Med. 2022 Sep 21;11(19):5540. doi: 10.3390/jcm11195540.
5
Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.用于预测局部晚期直肠癌新辅助放化疗病理完全缓解的深度学习模型
Front Oncol. 2022 Jun 8;12:807264. doi: 10.3389/fonc.2022.807264. eCollection 2022.
6
Predictive Value of the Prognostic Nutritional Index in Neoadjuvant Chemoradiotherapy for Rectal Cancer.预后营养指数在直肠癌新辅助放化疗中的预测价值
Cancer Diagn Progn. 2022 Jan 3;2(1):38-48. doi: 10.21873/cdp.10074. eCollection 2022 Jan-Feb.
7
Tumor-Infiltrating Lymphocytes as Biomarkers of Treatment Response and Long-Term Survival in Patients with Rectal Cancer: A Systematic Review and Meta-Analysis.肿瘤浸润淋巴细胞作为直肠癌患者治疗反应和长期生存的生物标志物:一项系统评价和荟萃分析
Cancers (Basel). 2022 Jan 27;14(3):636. doi: 10.3390/cancers14030636.
8
The "Immunoscore" in rectal cancer: could we search quality beyond quantity of life?直肠癌的“免疫评分”:我们能否在追求生命数量的同时追求生命质量?
Oncotarget. 2022 Jan 5;13:18-31. doi: 10.18632/oncotarget.28100. eCollection 2022.
肿瘤芽殖是与胰腺导管腺癌上皮间质转化相关的预后因素。研究报告和文献回顾。
Pancreatology. 2018 Jan;18(1):79-84. doi: 10.1016/j.pan.2017.11.010. Epub 2017 Nov 21.
4
Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer.活检样本中CD8 +淋巴细胞密度与循环淋巴细胞比率相结合可预测直肠癌放化疗后的病理完全缓解情况。
Cancer Manag Res. 2017 Nov 27;9:701-708. doi: 10.2147/CMAR.S150622. eCollection 2017.
5
Predictive clinical model of tumor response after chemoradiation in rectal cancer.直肠癌放化疗后肿瘤反应的预测性临床模型
Oncotarget. 2017 Jul 28;8(35):58133-58151. doi: 10.18632/oncotarget.19651. eCollection 2017 Aug 29.
6
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.新辅助放化疗后临床完全缓解的局部进展期直肠癌采用观察等待策略:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):501-513. doi: 10.1016/S2468-1253(17)30074-2. Epub 2017 May 4.
7
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.上皮-间质转化(EMT)与癌症干细胞:对胰腺癌治疗耐药性的影响
Mol Cancer. 2017 Feb 28;16(1):52. doi: 10.1186/s12943-017-0624-9.
8
Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome.局部晚期直肠癌新辅助治疗的病理反应及其对预后的影响。
J Gastrointest Oncol. 2016 Aug;7(4):603-8. doi: 10.21037/jgo.2016.05.03.
9
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.低基质Foxp3 +调节性T细胞密度与直肠癌新辅助放化疗的完全缓解相关。
Br J Cancer. 2015 Dec 22;113(12):1677-86. doi: 10.1038/bjc.2015.427. Epub 2015 Dec 8.
10
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.肿瘤细胞和基质细胞中E-钙黏蛋白抑制因子SNAIL、ZEB1和ZEB2的表达影响肿瘤芽生表型,并提示胰腺癌中基质细胞的异质性。
Br J Cancer. 2015 Jun 9;112(12):1944-50. doi: 10.1038/bjc.2015.177. Epub 2015 May 19.